JC

Jacqueline Carroll

Active Director Managing Director DIN 10824738
DIN 10824738 First appointment Oct 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Jacqueline Carroll

Data last updated:

Jacqueline Carroll is a Managing Director at Jacqs Pharma And Healthcare Private Limited (since 2024). The company operates in Paper.

DIN 10824738
Primary Designation Managing Director
Industry Paper
First Appointment 29 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director29 Oct 20242024Active

Board colleagues of Jacqueline Carroll

NameDINCompanyDesignation
Murugan Desappan11394890Jacqs Pharma And Healthcare Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Jacqs Pharma And Healthcare Private Limited
Premium access

Shareholding and investment profile for Jacqueline Carroll

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jacqueline Carroll

Jacqueline Carroll currently holds 1 directorship: Jacqs Pharma And Healthcare Private Limited (Managing Director, since 29 Oct 2024).

Jacqueline Carroll was first appointed on 29 Oct 2024 as Managing Director at Jacqs Pharma And Healthcare Private Limited.

The current boards of Jacqueline Carroll's companies include Murugan Desappan (Jacqs Pharma And Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available